| 注册
首页|期刊导航|国际医药卫生导报|重症急性胰腺炎持续血液净化治疗观察

重症急性胰腺炎持续血液净化治疗观察

彭怀力 陈玲 曹枫 陈荣琳 欧寿六

国际医药卫生导报2014,Vol.20Issue(17):2686-2688,3.
国际医药卫生导报2014,Vol.20Issue(17):2686-2688,3.DOI:10.3760/cma.j.issn.1007-1245.2014.17.023

重症急性胰腺炎持续血液净化治疗观察

Clinical observation on continuous blood purification therapy in treatment of severe acute pancreatitis

彭怀力 1陈玲 2曹枫 1陈荣琳 1欧寿六1

作者信息

  • 1. 518116 深圳市龙岗中心医院重症医学科
  • 2. 518116 深圳市龙岗中心医院神经内科
  • 折叠

摘要

Abstract

Objective To investigate the effect of continuous blood purification therapy in treatment of severe acute pancreatitis (SAP).Methods 23 patients were treated with traditional clinical medicine,23patients were treated on the basis of the former,with continuous blood purification (CBP) technology added,the inflammatory factors and other indicators of the situation in both groups were compared,Results There was significant difference of IL-1,IL-6,IL-8 and TNF-α treatment of two groups of patients in the time of 24h and 48h after treatment (P < 0.05),observed indexes were significantly lower than those of the control group [IL-1,IL-6,IL-8,TNF-α were (246.52 ± 31.84) pg/ml,(15.12 ± 1.07) pg/ml,(16.05 ± 1.08) pg/ml and (1.42 ± 0.31) ng/L 24 h after treatment (190.46 ± 27.65) pg/ml,(11.07 ± 1.87) pg/ml,(11.04 ± 1.57) pg/ml and (0.68 ± 0.34) ng/L 48 h after treatment respectively].There was significant difference of Ang-Ⅰ,Ang-Ⅱ,E,aldosterone in the treatment of the two groups patients in the time of 24 h and 48 h after treatment (P < 0.05) [Ang-Ⅰ,Ang-Ⅱ,E,ALD were (1.34 ± 1.17) ng/L,(0.72 ± 5.37) ng/L,(1.05 ± 0.21) ng/ml and (145.27 ± 15.34)pg/ml 24 h later,(9.28 ± 1.16) ng/L,(48.42 ± 4.10) ng/L,(0.63 ± 0.11) ng/ml and (99.31 ± 11,16) pg/ml 48 h later].Conclusion CBP can obviously alleviate the severity of SAP,and promote the inflammatory factors and improve the renin-angiotensin-aldosterone system.

关键词

持续性血液净化/重症急性胰腺炎/RAAS/炎性因子

Key words

Continuous blood purification/ Severe acute pancreatitis/ RAAS/ Inflammatory factor

引用本文复制引用

彭怀力,陈玲,曹枫,陈荣琳,欧寿六..重症急性胰腺炎持续血液净化治疗观察[J].国际医药卫生导报,2014,20(17):2686-2688,3.

国际医药卫生导报

1007-1245

访问量0
|
下载量0
段落导航相关论文